DLL4 and neoplasm: The results in this study demonstrate that these DLL4-driven differences in tumor vascular function directly impact nanoparticle distribution and response to photothermal therapy, thus DCE-MRI or other vascular function imaging alone or in combination with genomic profiling can be developed to identify tumors with favorable prognosis to nanoparticle therapies 25, 26.